Advertisement
Screener

Tilray Brands, Inc. (TLRY) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Tilray Brands, Inc. Amortization of Intangible Assets

Tilray Brands, Inc. (TLRY) reported Amortization of Intangible Assets of $24.29 million for the 3-month period ending 2022-02-28, per its 10-Q filed 2022-04-06.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2022-04-06

  • Tilray Brands, Inc. amortization of intangible assets for the quarter ending 2022-02-28 was $24.29M, a 969.75% increase year-over-year.
  • Tilray Brands, Inc. amortization of intangible assets for the quarter ending 2021-11-30 was $24.81M, a 629.83% increase year-over-year.
  • Tilray Brands, Inc. amortization of intangible assets for the quarter ending 2021-08-31 was $25.10M, a 807.74% increase year-over-year.
  • Tilray Brands, Inc. amortization of intangible assets for the quarter ending 2021-03-31 was $2.27M, a 22.29% increase year-over-year.
  • Tilray Brands, Inc. amortization of intangible assets for fiscal 2021 was $27.31M.
  • Tilray Brands, Inc. amortization of intangible assets for fiscal 2020 was $11.00M.
  • Tilray Brands, Inc. amortization of intangible assets for fiscal 2020 was $10.65M.
  • Tilray Brands, Inc. amortization of intangible assets for fiscal 2019 was $9.82M, a 2526.74% increase from fiscal 2018.
Period endAmortization of Intangible Assets 2 monthAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 5 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 8 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 11 monthAmortization of Intangible Assets 12 month
2022-02-28$24.29M
10-Q · filed 2022-04-06
$49.10M
derived: sum of 2 quarters · filed 2022-04-06
$74.20M
derived: sum of 3 quarters · filed 2022-04-06
$93.08M
derived: sum of 4 quarters · filed 2022-04-06
2021-11-30$24.81M
10-Q · filed 2022-04-06
$49.91M
derived: sum of 2 quarters · filed 2022-04-06
$68.78M
derived: sum of 3 quarters · filed 2022-04-06
2021-08-31$25.10M
10-Q · filed 2022-04-06
$43.98M
derived: sum of 2 quarters · filed 2022-04-06
2021-05-31$18.88M
derived: 10-K 12 month − 3 quarters · filed 2021-07-28
$27.31M
10-K · filed 2021-07-28
2021-03-31$2.27M
10-Q · filed 2021-05-10
$5.67M
derived: sum of 2 quarters · filed 2021-05-10
$8.44M
derived: sum of 3 quarters · filed 2021-05-10
$11.42M
derived: sum of 4 quarters · filed 2021-05-10
2020-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$6.16M
derived: sum of 2 quarters · filed 2021-02-19
$9.14M
derived: sum of 3 quarters · filed 2021-02-19
$11.00M
10-K · filed 2021-02-19
2020-09-30$2.77M
10-Q · filed 2020-11-09
$5.75M
derived: sum of 2 quarters · filed 2020-11-09
$7.60M
10-Q · filed 2020-11-09
$11.30M
derived: sum of 4 quarters · filed 2021-05-10
2020-06-30$2.98M
10-Q · filed 2020-08-10
$4.84M
10-Q · filed 2020-08-10
$8.53M
derived: sum of 3 quarters · filed 2021-05-10
$11.06M
derived: sum of 4 quarters · filed 2021-05-10
2020-05-31$10.65M
10-K · filed 2021-07-28
2020-03-31$1.86M
10-Q · filed 2021-05-10
$5.55M
derived: sum of 2 quarters · filed 2021-05-10
$8.08M
derived: sum of 3 quarters · filed 2021-05-10
$10.12M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$6.22M
derived: sum of 2 quarters · filed 2021-02-19
$8.27M
derived: sum of 3 quarters · filed 2021-02-19
$9.82M
10-K · filed 2021-02-19
2019-09-30$2.53M
10-Q · filed 2020-11-09
$4.57M
derived: sum of 2 quarters · filed 2020-11-09
$6.13M
10-Q · filed 2020-11-09
$6.16M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$2.04M
10-Q · filed 2020-08-10
$3.60M
10-Q · filed 2020-08-10
$3.63M
derived: sum of 3 quarters · filed 2021-02-19
$3.79M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$1.56M
10-Q · filed 2020-05-11
$1.58M
derived: sum of 2 quarters · filed 2021-02-19
$1.75M
derived: sum of 3 quarters · filed 2021-02-19
$1.85M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$193.00K
derived: sum of 2 quarters · filed 2021-02-19
$297.00K
derived: sum of 3 quarters · filed 2021-02-19
$374.00K
10-K · filed 2021-02-19
2018-09-30$169.00K
10-Q · filed 2018-11-14
$273.00K
derived: sum of 2 quarters · filed 2018-11-14
$350.00K
10-Q · filed 2018-11-14
2018-06-30$104.00K
10-Q · filed 2018-08-29
$180.00K
10-Q · filed 2018-08-29
2017-12-31$185.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$268.00K
derived: sum of 2 quarters · filed 2020-03-02
$340.00K
derived: sum of 3 quarters · filed 2020-03-02
$549.00K
10-K · filed 2020-03-02
2017-09-30$83.00K
10-Q · filed 2018-11-14
$155.00K
derived: sum of 2 quarters · filed 2018-11-14
$364.00K
10-Q · filed 2018-11-14
2017-06-30$72.00K
10-Q · filed 2018-08-29
$280.00K
10-Q · filed 2018-08-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87